Basic information
- Standard SMILES
CC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C- InChIKey
QGNJRVVDBSJHIZ-QHLGVNSISA-N- Molecular formula
- C22H32O2
- Average molar mass
- 328.5 g/mol
- Monoisotopic mass
- 328.24023026
Overview
Retinyl acetate is an acetate ester. It is functionally related to an all-trans-retinol.
Names & identifiers
- Preferred name
- Retinol, acetate
- IUPAC
- [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate
Names & synonyms
Show more names
Database identifiers
- CAS
127-47-9、64536-04-5- PubChem CID
- 638034
- DTXSID
DTXSID6021240- ChEMBL
CHEMBL486193- ChEBI
CHEBI:32095- UNII
- 3LE3D9D6OY
- EC Number
- 204-844-2
- Nikkaji
- J34.628D
Properties
Computed structural properties
- XLogP
- 6.3
- Topological polar surface area
- 26.3 Ų
- Hydrogen bond donors
- 0
- Hydrogen bond acceptors
- 2
- Rotatable bonds
- 7
- Heavy atoms
- 24
- Formal charge
- 0
- Complexity
- 595
Experimental & physicochemical properties
Safety & regulation
GHS classification
GHS Classification
This chemical does not meet GHS hazard criteria for 0.3% (1 of 374) of reports.
Danger
H315 (83.4%): Causes skin irritation [Warning Skin corrosion/irritation]
P203, P264, P273, P280, P302+P352, P318, P321, P332+P317, P362+P364, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 374 reports by companies from 22 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Regulatory Information
Chemical: Retinol, acetate
Regulation (EC) No 1831/2003 (amended)
REACH registered substance: Retinyl acetate (EC: 204-844-2)
Retinol acetate: Does not have an individual approval but may be used under an appropriate group standard
Toxicology
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.
Uses & manufacturing
Related reactions
Linked notes
Loading…